Period tracking apps like Clue can provide a practical tool for women on GLP-1 medications to monitor and detect subtle hormonal changes that clinical studies and general research would likely underreport
Staying properly hydrated with small, consistent sips of fluids helps prevent worsening stomach discomfort
Neurofibromatoses in clinical practice
In a meta-analyses of 137,895 individuals, RC was 43% lower in APOC3 loss-of-function heterozygotes versus noncarriers [53]
Figure 1 Data extraction First author name, country and year of publication, duration of the trial/weeks, duration of diabetes, age, gender, type and dose of GLP-1 agonists, total insulin dose in GLP-1 agonists and placebo arm, and the glycated hemoglobin in GLP-1 agonists and placebo were reported in tables and transferred manually to the RevMan, 5.4 for meta-analysis ( Tables 1 3 )
Weight loss occurred progressively during the first 60 weeks, and was maintained for the rest of the trial